Literature DB >> 19622387

Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.

Rodrigo A Quintanilla1, Gail V W Johnson.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that is caused by a pathological expansion of CAG repeats within the gene encoding for a 350 kD protein called huntingtin. This polyglutamine expansion within huntingtin is the causative factor in the pathogenesis of HD, however the underlying mechanisms have not been fully elucidated. Nonetheless, it is becoming increasingly clear that alterations in mitochondrial function play key roles in the pathogenic processes in HD. The net result of these events is compromised energy metabolism and increased oxidative damage, which eventually contribute to neuronal dysfunction and death. Mitochondria from striatal cells of a genetically accurate model of HD take up less calcium and at a slower rate than mitochondria from striatal cells derived from normal mice. Further, respiration in mitochondria from these mutant huntingtin-expressing cells is inhibited at significantly lower calcium concentrations compared to mitochondria from wild-type cells. Considering these and other findings this review explores the evidence suggesting that mutant huntingtin, directly or indirectly impairs mitochondrial function, which compromises cytosolic and mitochondrial calcium homeostasis, and contributes to neuronal dysfunction and death in HD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622387      PMCID: PMC2757461          DOI: 10.1016/j.brainresbull.2009.07.010

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  83 in total

1.  HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.

Authors:  Ihn Sik Seong; Elena Ivanova; Jong-Min Lee; Yeun Su Choo; Elisa Fossale; MaryAnne Anderson; James F Gusella; Jason M Laramie; Richard H Myers; Mathieu Lesort; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

Review 2.  3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.

Authors:  Emmanuel Brouillet; Carine Jacquard; Nicolas Bizat; David Blum
Journal:  J Neurochem       Date:  2005-11-21       Impact factor: 5.372

Review 3.  Nuclear control of respiratory gene expression in mammalian cells.

Authors:  Richard C Scarpulla
Journal:  J Cell Biochem       Date:  2006-03-01       Impact factor: 4.429

4.  Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice.

Authors:  Zemfira Z Gizatullina; Katrin S Lindenberg; Phoebe Harjes; Ying Chen; Christoph M Kosinski; Bernhard G Landwehrmeyer; Albert C Ludolph; Frank Striggow; Stephan Zierz; Frank N Gellerich
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

5.  Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.

Authors:  Randy L Hunter; Natasa Dragicevic; Kristen Seifert; Dong Young Choi; Mei Liu; Hyoung-Chun Kim; Wayne A Cass; Patrick G Sullivan; Guoying Bing
Journal:  J Neurochem       Date:  2007-01-23       Impact factor: 5.372

Review 6.  Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle.

Authors:  Brigit E Riley; Harry T Orr
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

Review 7.  PPARgamma as a therapeutic target in central nervous system diseases.

Authors:  Sophia Sundararajan; Qingguang Jiang; Michael Heneka; Gary Landreth
Journal:  Neurochem Int       Date:  2006-06-12       Impact factor: 3.921

8.  Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.

Authors:  Jacqueline Shehadeh; Herman B Fernandes; Melinda M Zeron Mullins; Rona K Graham; Blair R Leavitt; Michael R Hayden; Lynn A Raymond
Journal:  Neurobiol Dis       Date:  2005-09-13       Impact factor: 5.996

9.  SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells.

Authors:  Marcia C Haigis; Raul Mostoslavsky; Kevin M Haigis; Kamau Fahie; Danos C Christodoulou; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Margaret Karow; Gil Blander; Cynthia Wolberger; Tomas A Prolla; Richard Weindruch; Frederick W Alt; Leonard Guarente
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

10.  Rosiglitazone induces mitochondrial biogenesis in mouse brain.

Authors:  Jay C Strum; Ron Shehee; David Virley; Jill Richardson; Michael Mattie; Paula Selley; Sujoy Ghosh; Christina Nock; Ann Saunders; Allen Roses
Journal:  J Alzheimers Dis       Date:  2007-03       Impact factor: 4.472

View more
  54 in total

1.  Microcirculation response to local cooling in patients with Huntington's disease.

Authors:  Ziva Melik; Jan Kobal; Ksenija Cankar; Martin Strucl
Journal:  J Neurol       Date:  2011-10-20       Impact factor: 4.849

2.  Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2).

Authors:  Yoshiaki Tanaka; Kun-Yong Kim; Mei Zhong; Xinghua Pan; Sherman Morton Weissman; In-Hyun Park
Journal:  Hum Mol Genet       Date:  2013-10-15       Impact factor: 6.150

3.  Neuroprotective effects of white tea against oxidative stress-induced toxicity in striatal cells.

Authors:  M P Almajano; I Vila; S Gines
Journal:  Neurotox Res       Date:  2011-06-23       Impact factor: 3.911

4.  Targeting sirtuin-1 in Huntington's disease: rationale and current status.

Authors:  Wenzhen Duan
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

5.  Impaired Mitochondrial Fatty Acid Synthesis Leads to Neurodegeneration in Mice.

Authors:  Remya R Nair; Henna Koivisto; Kimmo Jokivarsi; Ilkka J Miinalainen; Kaija J Autio; Aki Manninen; Pekka Poutiainen; Heikki Tanila; J Kalervo Hiltunen; Alexander J Kastaniotis
Journal:  J Neurosci       Date:  2018-09-28       Impact factor: 6.167

6.  D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice.

Authors:  Kodeeswaran Parameshwaran; Michael H Irwin; Kosta Steliou; Carl A Pinkert
Journal:  Rejuvenation Res       Date:  2011-01-04       Impact factor: 4.663

Review 7.  PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Authors:  Taiji Tsunemi; Albert R La Spada
Journal:  Prog Neurobiol       Date:  2011-11-09       Impact factor: 11.685

Review 8.  How to bake a brain: yeast as a model neuron.

Authors:  Isabella Sarto-Jackson; Lubomir Tomaska
Journal:  Curr Genet       Date:  2016-01-18       Impact factor: 3.886

Review 9.  Ca(2+) signaling: an outlook on the characterization of Ca(2+) channels and their importance in cellular functions.

Authors:  Jordan Karlstad; Yuyang Sun; Brij B Singh
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

10.  Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.

Authors:  Jing Jin; Jennifer Albertz; Zhihong Guo; Qi Peng; Gay Rudow; Juan C Troncoso; Christopher A Ross; Wenzhen Duan
Journal:  J Neurochem       Date:  2013-03-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.